Billionaires Holding CLVS

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 34.0M
    Shares Outstanding

  • 1.637B
    Market Cap

News & Insights

ABOUT

CLVS

Clovis Oncology Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. Clovis target its development programs for the treatment of specific subsets o...

Hedge funds hate Apple ... but love Facebook

NEWS

BRIEF-Berkshire Hathaway buys about 824,000 shares of Phillips 66

READ MORE